Community/Retail

Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.

Options abound, but pharmacists should address barriers to prevent inequities for patients when they seek treatment.

Patients with HIV were no less likely to show a worse clinical presentation following tecovirimat treatment.

Brexpiprazole was associated with a statistically and clinically meaningful improvement in agitative behaviors caused by dementia compared to placebo.

Nonprescription products manage mild to moderate symptoms, but more severe cases need further medical evaluation.

Harsha Rajasimha, PhD, discusses current challenges leading to clinical trial delays, such as the “valley of death.”

Although this should be a relatively routine process, the national conversations around abortion and contraception have brought more attention to the decision.

BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.

Study shows that the nervous system of individuals experiencing post-COVID-19 fatigue is underactive in 3 key areas.

Investigators found that providing parents with a hypothetical scenario outlining why they should immunize their children against COVID-19 was effective in improving vaccination rates.

Atogepant reduced mean monthly migraine days by more than 2 days compared to placebo in the ELEVATE trial.

Anthony Pudlo, PharmD, MBA, executive director of the Tennessee Pharmacists Association, discusses his presentation at the National Association of Chain Drug Stores (NACDS) 2023 Regional Chain conference.

A new FDA policy would assess blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.

This treatment approach helps reduce symptoms and future exacerbations triggered by dust mites, pet dander, pollen.

Health systems must address drivers of attrition, turnover.

Although some pharmacy employees have left the profession, others have stayed but changed direction.

Tackling racial disparities among health care providers can help improve disparities faced by patients.

Closely monitored, decentralized trials have also been shown to improve electronic patient reported outcomes to 92% compliance, according to ObvioHealth.

An FDA committee voted 17-0 to make the once-daily birth control medication Opill available OTC after deciding the benefits outweigh any potential harms.

Redefining technician roles boosts workflow efficiencies, strengthens pharmacies' bottom lines.

Commonly, essential yet routine and time-consuming tasks, such as answering phone calls, scheduling appointments, or other administrative work, prevent health care workers from focusing on more value-added and enjoyable job functions.

During a fireside chat, USP CEO Ronald T. Piervincenzi, PhD, and the Honorable Dr. Oh Yu-Kyoung, Minister of MFDS, Republic of Korea, discuss interruptions to the medical supply chain and the interventions used.

As patents expire, the development of biosimilars may increase, opening up new opportunities to compare efficacies of these drugs.

Naiffer Romero, MSc, MPH, discusses his work at U.S. Pharmacopeia to regulate nitrosamine impurities and ensure medication quality.

Dapagliflozin was established as the first SGLT2 inhibitor that demonstrated a mortality benefit for cardiovascular death from heart failure.

With or without US federal regulation, CBD companies should provide consumers with more transparent information about their products.

Joanna Lewis and Pooja Lakshmin, MD, discuss Lakshmin's new book, "Real Self-Care," and women's mental health.

Shweta S. Namjoshi, MD, MPH, CNSC, discusses the role of the pharmacists in gastrointestinal care and the differences in care for pediatrics and adults.

Evidence suggest better outcomes results when a program is responsive to the significant needs of this population.

Lack of awareness, or anosognosia, may be present up to 2 to 3 years before an Alzheimer dementia diagnosis is made.